In our study, as the severity of emphysema increased, the frequency of Foxp3+GARP+ gradually decreased, while Foxp3+GARP− continuously increased, suggesting that compromised immunomodulatory capacity and enhanced pro-inflammatory capacity are involved in the pathogenesis of emphysema. Here, FOXP3 is linked to pulmonary emphysema.